Probiotics in inflammatory bowel disease--therapeutic rationale and role.
about
Probiotic agents for the treatment of diarrhoea-predominant irritable bowel syndromeImmunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteriaAn important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum.Bile salt hydrolase activity in probiotics.Prebiotics to fight diseases: reality or fiction?The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role.Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells.Alteration of the canine small-intestinal lactic acid bacterium microbiota by feeding of potential probiotics.Brain-gut-microbe communication in health and disease.Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons.Exercise Modifies the Gut Microbiota with Positive Health EffectsRole of genes, the environment and their interactions in the etiology of inflammatory bowel diseases.Functional foods and paediatric gastro-intestinal health and disease.Application of prodrugs to inflammatory diseases of the gut.Probiotics and their derivatives as treatments for inflammatory bowel disease.Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease.Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis.Why interleukin-10 supplementation does not work in Crohn's disease patients.Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis.Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats.Probiotic Properties of Lyophilized Cell Free Extract of Lactobacillus casei.Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli.Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease.Biochemical and pathological evidences on the benefit of a new biodegradable nanoparticles of probiotic extract in murine colitis.Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria.A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch.The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human
P2860
Q24244086-26A3798B-3C24-498B-9D60-959B7E69B506Q28730618-48CF0773-19C9-475B-9C07-D6CC7927293EQ34297879-D76E532A-9AE6-4905-8131-18F28724D522Q34432358-37E7B581-6D79-43BC-9013-CF66A3AC5B1BQ34529060-D498C748-14A4-4194-9FC9-E895EABC70CAQ34547396-821FD64D-DEE6-4A1B-B872-794D0466DA68Q34726615-7D5D6EB7-C3F3-4EC5-B907-03B487946440Q35091931-AA337232-1F01-47E0-B05B-9565DD46B1FFQ35597520-01D914E5-8ACD-4B00-A721-A87EB86BE4F9Q35795929-4BAB95E5-7114-4751-A335-FE8E7D5A932FQ36327600-3654B4B7-E994-4F81-94CA-920C86190281Q36481111-673DA4B3-F5F1-4458-8E5F-7A6E19E3A4D8Q36482197-BEE80F71-630B-4975-9D31-F8CB5C5D6C14Q37096512-35E239F9-687A-4023-B4F6-724780D57409Q37448522-2BC662EE-2F49-4C65-BF15-C25730F7A108Q37576939-340A63D1-AA0A-4EC1-BF3E-9B236C912D1BQ37851431-97859A00-8F56-4AA3-9E54-57EE191A34CAQ38120519-1F876CB2-5785-4F6A-B2BC-65D6634F1707Q40094968-4FFDDA75-8F14-4739-96FF-F572B0FA9130Q41901947-0B635245-C0C4-448F-93FD-9D57A208B136Q41997023-83EAF7BA-E00C-47E4-95AD-43BD5D4F66F1Q42267314-8BF1C90B-792E-49D0-B73F-4A13E7027AAEQ42788674-8B1A5659-AEC4-4734-B5D2-D163BDE91623Q44023499-2E05365B-0FD2-48C1-9F4E-22D29E48ED11Q45811186-6C90AD90-80B3-4500-92D9-56C72CB6057FQ50081572-4B350902-8C01-45F4-A86B-19687E4B4ABBQ54441343-79236BA3-7481-44E4-A5AD-3EEB37502AECQ54477197-FF1B03E1-9995-4FAB-90C8-CA17741FA0B3Q58802621-05329AEA-3EBB-4C3A-8625-068430D02390
P2860
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
@ast
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
@en
type
label
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
@ast
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
@en
prefLabel
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
@ast
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
@en
P1476
Probiotics in inflammatory bowel disease--therapeutic rationale and role.
@en
P2093
Fergus Shanahan
P304
P356
10.1016/J.ADDR.2003.11.003
P407
P577
2004-04-01T00:00:00Z